These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15713685)

  • 21. Insulin action during late pregnancy in the conscious dog.
    Connolly CC; Aglione LN; Smith MS; Lacy DB; Moore MC
    Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E909-15. PubMed ID: 14749203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of hepatic denervation on peripheral insulin sensitivity in conscious dogs.
    Moore MC; Satake S; Baranowski B; Hsieh PS; Neal DW; Cherrington AD
    Am J Physiol Endocrinol Metab; 2002 Feb; 282(2):E286-96. PubMed ID: 11788359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of glargine insulin versus rosiglitazone addition in poorly controlled type 2 diabetic patients on metformin plus sulfonylurea.
    Triplitt C; Glass L; Miyazaki Y; Wajcberg E; Gastaldelli A; De Filippis E; Cersosimo E; DeFronzo RA
    Diabetes Care; 2006 Nov; 29(11):2371-7. PubMed ID: 17065670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic glucose autoregulation: responses to small, non-insulin-induced changes in arterial glucose.
    Camacho RC; Lacy DB; James FD; Coker RH; Wasserman DH
    Am J Physiol Endocrinol Metab; 2004 Aug; 287(2):E269-74. PubMed ID: 15053988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Superior Glycemic Control With a Glucose-Responsive Insulin Analog: Hepatic and Nonhepatic Impacts.
    Moore MC; Kelley DE; Camacho RC; Zafian P; Ye T; Lin S; Kaarsholm NC; Nargund R; Kelly TM; Van Heek M; Previs SF; Moyes C; Smith MS; Farmer B; Williams P; Cherrington AD
    Diabetes; 2018 Jun; 67(6):1173-1181. PubMed ID: 29540491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective antagonism of the hepatic glucocorticoid receptor reduces hepatic glucose production.
    Edgerton DS; Jacobson PB; Opgenorth TJ; Zinker B; Beno D; von Geldern T; Ohman L; Scott M; Neal D; Cherrington AD
    Metabolism; 2006 Sep; 55(9):1255-62. PubMed ID: 16919547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes.
    Cervera A; Wajcberg E; Sriwijitkamol A; Fernandez M; Zuo P; Triplitt C; Musi N; DeFronzo RA; Cersosimo E
    Am J Physiol Endocrinol Metab; 2008 May; 294(5):E846-52. PubMed ID: 18334612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid translocation of hepatic glucokinase in response to intraduodenal glucose infusion and changes in plasma glucose and insulin in conscious rats.
    Chu CA; Fujimoto Y; Igawa K; Grimsby J; Grippo JF; Magnuson MA; Cherrington AD; Shiota M
    Am J Physiol Gastrointest Liver Physiol; 2004 Apr; 286(4):G627-34. PubMed ID: 14656711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of an acute elevation of NEFA concentrations on glucagon-stimulated hepatic glucose output.
    Everett-Grueter C; Edgerton DS; Donahue EP; Vaughan S; Chu CA; Sindelar DK; Cherrington AD
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E449-59. PubMed ID: 16608886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infection impairs insulin-dependent hepatic glucose uptake during total parenteral nutrition.
    Donmoyer CM; Chen SS; Lacy DB; Pearson DA; Poole A; Zhang Y; McGuinness OP
    Am J Physiol Endocrinol Metab; 2003 Mar; 284(3):E574-82. PubMed ID: 12441309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the portal signal in a nonsteady hyperglycemic state in conscious dogs.
    Ogihara N; Ebihara S; Kawamura W; Okamoto M; Sakai T; Takiguchi K; Morita T; Uchida R; Matsuyama Y; Hayashi Y; Arakawa Y; Kikuchi M
    Am J Physiol Endocrinol Metab; 2003 Jan; 284(1):E148-55. PubMed ID: 12388150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Initially more rapid small intestinal glucose delivery increases plasma insulin, GIP, and GLP-1 but does not improve overall glycemia in healthy subjects.
    Chaikomin R; Doran S; Jones KL; Feinle-Bisset C; O'Donovan D; Rayner CK; Horowitz M
    Am J Physiol Endocrinol Metab; 2005 Sep; 289(3):E504-7. PubMed ID: 15886226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of the glucagon-like peptide-1 receptor agonist lixisenatide on postprandial hepatic glucose metabolism in the conscious dog.
    Moore MC; Werner U; Smith MS; Farmer TD; Cherrington AD
    Am J Physiol Endocrinol Metab; 2013 Dec; 305(12):E1473-82. PubMed ID: 24148347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of the vagus nerves in the regulation of basal hepatic glucose production in conscious dogs.
    Cardin S; Walmsley K; Neal DW; Williams PE; Cherrington AD
    Am J Physiol Endocrinol Metab; 2002 Nov; 283(5):E958-64. PubMed ID: 12376322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FK-614, a selective peroxisome proliferator-activated receptor gamma agonist, improves peripheral glucose utilization while decreasing hepatic insulin extraction in alloxan-induced diabetic dogs.
    Uchino H; Kim T; Lam TK; Yoshii H; Klement P; Williams W; Kawamori R; Giacca A
    Metabolism; 2005 Sep; 54(9):1250-8. PubMed ID: 16125538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhalation of insulin (Exubera) is associated with augmented disposal of portally infused glucose in dogs.
    Edgerton DS; Neal DW; Scott M; Bowen L; Wilson W; Hobbs CH; Leach C; Sivakumaran S; Strack TR; Cherrington AD
    Diabetes; 2005 Apr; 54(4):1164-70. PubMed ID: 15793257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhalation of human insulin is associated with improved insulin action compared with subcutaneous injection and endogenous secretion in dogs.
    Edgerton DS; Stettler KM; Neal DW; Scott M; Bowen L; Wilson W; Hobbs CH; Leach C; Strack TR; Cherrington AD
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1258-64. PubMed ID: 16963622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of portal free fatty acid elevation on insulin clearance and hepatic glucose flux.
    Yoshii H; Lam TK; Gupta N; Goh T; Haber CA; Uchino H; Kim TT; Chong VZ; Shah K; Fantus IG; Mari A; Kawamori R; Giacca A
    Am J Physiol Endocrinol Metab; 2006 Jun; 290(6):E1089-97. PubMed ID: 16390863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Understanding postprandial glucose clearance by peripheral organs: the role of the hepatic parasympathetic system.
    Fernandes AB; Patarrão RS; Videira PA; Macedo MP
    J Neuroendocrinol; 2011 Dec; 23(12):1288-95. PubMed ID: 21933289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison between closed-loop portal and peripheral venous insulin delivery systems for an artificial endocrine pancreas.
    Sekigami T; Shimoda S; Nishida K; Matsuo Y; Ichimori S; Ichinose K; Shichiri M; Sakakida M; Araki E
    J Artif Organs; 2004; 7(2):91-100. PubMed ID: 15309676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.